ArticleJournal of translational internal medicine2025

Development of a broadly potent neutralizing antibody targeting Nidogen 1 effectively inhibits cancer growth and metastasis in preclinical tumor models.

Tingmao Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.